Core Viewpoint - Shiliu Cloud Medical has officially listed on NASDAQ under the ticker symbol POM, raising $20 million through the issuance of 5 million shares at an initial price of $4 per share [1] Company Overview - Shiliu Cloud Medical is an online healthcare service platform focused on chronic disease management, aiming to create a closed-loop system involving "medical, pharmaceutical, patient, testing, and insurance" [1] - The company is projected to generate revenue of $46.93 million in 2024, with a net loss of $5.12 million [1]

Core Points - Shiliuyun Medical officially listed on NASDAQ on October 8, 2023, under the stock code POM, becoming the first Chinese company to go public in the U.S. in October [1] - The opening price was $4.5 per share, a 12.5% increase from the IPO price of $4, with a closing price of $4.03, resulting in a total market capitalization of $477 million [1] - The company raised $20 million by issuing 5 million shares, with plans to use the funds for supply chain inventory, expanding its departments and geographical coverage, research and development, and general corporate purposes [1] Company Overview - Shiliuyun Medical is an online medical service platform focused on chronic disease management, aiming to create a closed-loop system involving doctors, medications, patients, testing, and insurance [1] - For the year 2024, the company projects revenue of $46.93 million and a net loss of $5.12 million [1] Shareholding Structure - After the IPO, Zhenvang Shi holds 29% of the shares with 76% voting power, while Li Xu holds 4.1% [2] - Major shareholders include HEAL THYSEVEN LIMITED with 18.6% ownership and 46.3% voting power, and Dan Hong (H.K.) Technology Limited with 15.6% ownership and 5.1% voting power [2]